Cover Image

Isotopic Radiolabeling of the Antiretroviral Drug [<sup>18</sup>F]Dolutegravir for Pharmacokinetic PET Imaging

Deciphering the drug/virus/host interactions at infected cell reservoirs is a key leading to HIV-1 remission for which positron emission tomography (PET) imaging using radiolabeled antiretroviral (ARV) drugs is a powerful asset. Dolutegravir (DTG) is one of the preferred therapeutic options to treat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Marion Tisseraud (Author), Sébastien Goutal (Author), Thomas Bonasera (Author), Maud Goislard (Author), Delphine Desjardins (Author), Roger Le Grand (Author), Chris M. Parry (Author), Nicolas Tournier (Author), Bertrand Kuhnast (Author), Fabien Caillé (Author)
Format:	Book
Published:	MDPI AG, 2022-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Isotopic Radiolabeling of Crizotinib with Fluorine-18 for In Vivo Pet Imaging
by: Malvika Sardana, et al.
Published: (2022)

Impact of Cytochrome Induction or Inhibition on the Plasma and Brain Kinetics of [<sup>11</sup>C]metoclopramide, a PET Probe for P-Glycoprotein Function at the Blood-Brain Barrier
by: Louise Breuil, et al.
Published: (2022)

<sup>18</sup>F-Radiolabeled Translocator Protein (TSPO) PET Tracers: Recent Development of TSPO Radioligands and Their Application to PET Study
by: Truong Giang Luu, et al.
Published: (2022)

Pharmacokinetic Imaging Using <sup>99m</sup>Tc-Mebrofenin to Untangle the Pattern of Hepatocyte Transporter Disruptions Induced by Endotoxemia in Rats
by: Solène Marie, et al.
Published: (2022)

[<sup>18</sup>F]2-Fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Monitoring of Enhanced Blood-Brain Barrier Permeability Induced by Focused Ultrasound
by: Gaëlle Hugon, et al.
Published: (2021)

Comparison of the Blood-Brain Barrier Transport and Vulnerability to P-Glycoprotein-Mediated Drug-Drug Interaction of Domperidone versus Metoclopramide Assessed Using In Vitro Assay and PET Imaging
by: Louise Breuil, et al.
Published: (2022)

The Different Strategies for the Radiolabeling of [<sup>211</sup>At]-Astatinated Radiopharmaceuticals
by: Jie Gao, et al.
Published: (2024)

Standardization of the [<sup>68</sup>Ga]Ga-PSMA-11 Radiolabeling Protocol in an Automatic Synthesis Module: Assessments for PET Imaging of Prostate Cancer
by: Leonardo L. Fuscaldi, et al.
Published: (2021)

Synthesis and Preclinical Evaluation of Radiolabeled [<sup>103</sup>Ru]BOLD-100
by: Barbara Happl, et al.
Published: (2023)

Preparation and Preliminary Evaluation of Neurotensin Radiolabelled with <sup>68</sup>Ga and <sup>177</sup>Lu as Potential Theranostic Agent for Colon Cancer
by: Radu Anton Leonte, et al.
Published: (2021)

Simultaneous Visualization of <sup>161</sup>Tb- and <sup>177</sup>Lu-Labeled Somatostatin Analogues Using Dual-Isotope SPECT Imaging
by: Francesca Borgna, et al.
Published: (2021)

Functionalization of <sup>68</sup>Ga-Radiolabeled Nanodiamonds with Octreotide Does Not Improve Tumor-Targeting Capabilities
by: Thomas Wanek, et al.
Published: (2024)

[<sup>68</sup>Ga]FAPI PET for Imaging and Treatment Monitoring in a Preclinical Model of Pulmonary Fibrosis: Comparison to [<sup>18</sup>F]FDG PET and CT
by: Hao Ji, et al.
Published: (2024)

<sup>68</sup>Ga-Radiolabeling and Pharmacological Characterization of a Kit-Based Formulation of the Gastrin-Releasing Peptide Receptor (GRP-R) Antagonist RM2 for Convenient Preparation of [<sup>68</sup>Ga]Ga-RM2
by: Adrien Chastel, et al.
Published: (2021)

[<sup>18</sup>F]F-PSMA-1007 Radiolabelling without an On-Site Cyclotron: A Quality Issue
by: Valentina Di Iorio, et al.
Published: (2021)

[<sup>68</sup>Ga]Ga-DOTA-TOC: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging
by: Ute Hennrich, et al.
Published: (2020)

Preparation, Radiolabeling with <sup>68</sup>Ga/<sup>177</sup>Lu and Preclinical Evaluation of Novel Angiotensin Peptide Analog: A New Class of Peptides for Breast Cancer Targeting
by: Subhani M. Okarvi
Published: (2023)

[<sup>68</sup>Ga]Ga-PSMA-11: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
by: Ute Hennrich, et al.
Published: (2021)

Efficient Production of the PET Radionuclide <sup>133</sup>La for Theranostic Purposes in Targeted Alpha Therapy Using the <sup>134</sup>Ba(p,2n)<sup>133</sup>La Reaction
by: Santiago Andrés Brühlmann, et al.
Published: (2022)

Complex Diagnostic Challenges in Glioblastoma: The Role of <sup>18</sup>F-FDOPA PET Imaging
by: David Sipos, et al.
Published: (2024)

Development of <sup>18</sup>F-Labeled Bispyridyl Tetrazines for In Vivo Pretargeted PET Imaging
by: Rocío García-Vázquez, et al.
Published: (2022)

Imaging-Based Characterization of a <i>Slco2b1<sup>(-/-)</sup></i> Mouse Model Using [<sup>11</sup>C]Erlotinib and [<sup>99m</sup>Tc]Mebrofenin as Probe Substrates
by: Solène Marie, et al.
Published: (2021)

Towards Facile Radiolabeling and Preparation of Gallium-68-/Bismuth-213-DOTA-[Thi<sup>8</sup>, Met(O<sub>2</sub>)<sup>11</sup>]-Substance P for Future Clinical Application: First Experiences
by: Janine Suthiram, et al.
Published: (2021)

Development of a Promising <sup>18</sup>F-Radiotracer for PET Imaging Legumain Activity In Vivo
by: Chunmei Lu, et al.
Published: (2022)

Comparative Study of Two Oxidizing Agents, Chloramine T and Iodo-Gen<sup>®</sup>, for the Radiolabeling of β-CIT with Iodine-131: Relevance for Parkinson's Disease
by: Ana Claudia R. Durante, et al.
Published: (2019)

[<sup>68</sup>Ga]Ga-FAP-2286-Synthesis, Quality Control and Comparison with [<sup>18</sup>F]FDG PET/CT in a Patient with Suspected Cholangiocellular Carcinoma
by: Anton Amadeus Hörmann, et al.
Published: (2024)

Head-to-Head Comparison between [<sup>68</sup>Ga]Ga-DOTA.SA.FAPi and [<sup>18</sup>F]F-FDG PET/CT Imaging in Patients with Breast Cancer
by: Sanjana Ballal, et al.
Published: (2023)

Optimized <sup>68</sup>Ga-Labeled Urea-Based PSMA-Targeted PET Tracers for Prostate Cancer
by: Yitian Wu, et al.
Published: (2022)

Synthesis of <sup>68</sup>Ga-Labeled cNGR-Based Glycopeptides and In Vivo Evaluation by PET Imaging
by: Barbara Gyuricza, et al.
Published: (2021)

Binding Parameters of [<sup>11</sup>C]MPC-6827, a Microtubule-Imaging PET Radiopharmaceutical in Rodents
by: Avinash H. Bansode, et al.
Published: (2023)

Toward Optimized <sup>89</sup>Zr-Immuno-PET: Side-by-Side Comparison of [<sup>89</sup>Zr]Zr-DFO-, [<sup>89</sup>Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [<sup>89</sup>Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?
by: Helen Damerow, et al.
Published: (2022)

Therapeutic Response of CCKBR-Positive Tumors to Combinatory Treatment with Everolimus and the Radiolabeled Minigastrin Analogue [<sup>177</sup>Lu]Lu-PP-F11N
by: Michal Grzmil, et al.
Published: (2021)

Contribution of [<sup>18</sup>F]FET PET in the Management of Gliomas, from Diagnosis to Follow-Up: A Review
by: Jade Apolline Robert, et al.
Published: (2024)

PET Imaging with [<sup>18</sup>F]ROStrace Detects Oxidative Stress and Predicts Parkinson's Disease Progression in Mice
by: Yi Zhu, et al.
Published: (2024)

Can the Efficacy of [<sup>18</sup>F]FDG-PET/CT in Clinical Oncology Be Enhanced by Screening Biomolecular Profiles?
by: Hazel O'Neill, et al.
Published: (2019)

<sup>68</sup>Ga-HBED-CC-WL-12 PET in Diagnosing and Differentiating Pancreatic Cancers in Murine Models
by: Qiying Xiang, et al.
Published: (2023)

A High-Affinity <sup>64</sup>Cu-Labeled Ligand for PET Imaging of Hepsin: Design, Synthesis, and Characterization
by: Ji-Hun Park, et al.
Published: (2022)

GMP-Compliant Radiosynthesis of [<sup>18</sup>F]GP1, a Novel PET Tracer for the Detection of Thrombi
by: Verena Hugenberg, et al.
Published: (2021)

<sup>68</sup>Ga-Labeling: Laying the Foundation for an Anti-Radiolytic Formulation for NOTA-sdAb PET Tracers
by: Henri Baudhuin, et al.
Published: (2021)

The place of <sup>18</sup>F FDG PET/CT in the management of patients with eosinophilic fasciitis: a case report
by: N. Belfeki, et al.
Published: (2021)